Amino acid alterations and encephalopathy in the sepsis syndrome
- PMID: 2055050
- DOI: 10.1097/00003246-199106000-00004
Amino acid alterations and encephalopathy in the sepsis syndrome
Abstract
Objective: To evaluate the role of amino acid profiles in septic encephalopathy.
Design: Retrospective analysis.
Setting: Medical wards and medical ICU of a university hospital.
Patients: Patients with infections and normal mental status were compared with patients with septic shock and altered sensorium.
Interventions: Plasma amino acid levels and Acute Physiology and Chronic Health Evaluation (APACHE II) scores were determined.
Measurements and main results: Patients with septic shock and altered sensorium had higher circulating concentrations of ammonia (425 +/- 55 vs. 127 +/- 7 mmol/L) and the aromatic amino acids phenylalanine (122 +/- 19 vs. 74 +/- 3 mmol/L) and tryptophan (97 +/- 7 vs. 32 +/- 13 mmol/L), and lower levels of the branch-chain amino acid isoleucine (48 +/- 7 vs. 68 +/- 5 mmol/L) than patients with infections and normal sensorium (p less than .05). Aromatic amino acid levels correlated with APACHE II scores (R2 = .4, p less than .001) and mortality. APACHE II scores were higher in the septic shock patients (30 +/- 2 vs. 8 +/- 1, p less than .001), and these patients had a higher mortality rate (71% vs. 12%, p less than .01). Patients with septic shock who died had higher levels of ammonia (524 +/- 58 vs. 227 +/- 40 mmol/L, p less than .05) and sulfur-containing amino acids (172 +/- 31 vs. 61 +/- 7 mmol/L, p less than .05) than patients who survived.
Conclusions: Plasma amino acid profiles appear to be important in septic encephalopathy and the severity of septic disease.
Similar articles
-
Septic shock: an analysis of outcomes for patients with onset on hospital wards versus intensive care units.Crit Care Med. 1998 Jun;26(6):1020-4. doi: 10.1097/00003246-199806000-00019. Crit Care Med. 1998. PMID: 9635649
-
Plasma granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor levels in critical illness including sepsis and septic shock: relation to disease severity, multiple organ dysfunction, and mortality.Crit Care Med. 2000 Jul;28(7):2344-54. doi: 10.1097/00003246-200007000-00028. Crit Care Med. 2000. PMID: 10921563
-
[The significance of lactic acid in early diagnosis and goal-directed therapy of septic shock patients].Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2014 Jan;26(1):51-5. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2014. PMID: 24649525 Clinical Trial. Chinese.
-
Septic encephalopathy. Etiology and management.Intensive Care Med. 1986;12(1):13-6. doi: 10.1007/BF00315361. Intensive Care Med. 1986. PMID: 2872241 Review.
-
[Septic encephalopathy. Diagnosis und therapy].Anaesthesist. 2003 Apr;52(4):294-303. doi: 10.1007/s00101-003-0496-9. Anaesthesist. 2003. PMID: 12715131 Review. German.
Cited by
-
Patient Stratification in Sepsis: Using Metabolomics to Detect Clinical Phenotypes, Sub-Phenotypes and Therapeutic Response.Metabolites. 2022 Apr 21;12(5):376. doi: 10.3390/metabo12050376. Metabolites. 2022. PMID: 35629881 Free PMC article. Review.
-
Serum Phenylalanine, Tyrosine, and their Ratio in Acute Ischemic Stroke: on the Trail of a Biomarker?J Mol Neurosci. 2016 Jan;58(1):102-8. doi: 10.1007/s12031-015-0659-6. Epub 2015 Sep 30. J Mol Neurosci. 2016. PMID: 26423306
-
Imaging in sepsis-associated encephalopathy--insights and opportunities.Nat Rev Neurol. 2013 Oct;9(10):551-61. doi: 10.1038/nrneurol.2013.177. Epub 2013 Sep 3. Nat Rev Neurol. 2013. PMID: 23999468 Review.
-
Science review: The brain in sepsis--culprit and victim.Crit Care. 2005 Feb;9(1):37-44. doi: 10.1186/cc2951. Epub 2004 Sep 8. Crit Care. 2005. PMID: 15693982 Free PMC article. Review.
-
Central role of microglia in sepsis-associated encephalopathy: From mechanism to therapy.Front Immunol. 2022 Jul 26;13:929316. doi: 10.3389/fimmu.2022.929316. eCollection 2022. Front Immunol. 2022. PMID: 35958583 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical